AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Gastric Recalibration After Endoscopic Sleeve Gastroplasty

RecruitingNAAges 18 Years - 75 YearsAllIHU Strasbourg
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Endoscopic sleeve gastroplasty (ESG) is a technique used for bariatric surgery, with results comparable to conventional surgery, in order to treat morbid obesity. It has also less risks of complications, and it is not an irreversible technique. It can be repeated overtime, regarding the evolution of the gastroplasty. There is little data in the literature on the effectiveness of endoscopic "revision". This study will assess the benefits and costs of a revision during the follow-up endoscopy.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 to 75 * Patients with morbid obesity (BMIโ‰ฅ 30 with comorbidities or\> 40) * Patients with obesity for more than 2 years * Failure of medical treatment of obesity * Patients who may benefit from general anaesthesia * Patient able to participate in all aspects of the study and that agree to comply with all study requirements, for the duration of the study. This includes the availability of reliable transportation and sufficient time to attend all follow-up visits. * Patient able to fully understand the study and ready to give consent to participate to the study. * Patient affiliated to the French social security system Exclusion Criteria: * Patient with a contraindication to perform an ESG * Patient with a history of previous bariatric, gastric or esophageal surgery. * Patient who initiated medical therapy within the last 3 months, with evidence of weight gain. * Patient with an uncontrolled, poorly controlled, or suspected history of eating disorders or psychiatric illness. * Patient with unstable and precarious state of health, as determined and assessed by the investigator. * Patient who is pregnant, breastfeeding or of childbearing age and without effective contraception. * Patient in exclusion period (determined by a previous or ongoing study) * Patient under legal protection * Patient under guardianship or curatorship * Patients with a BMI less than 30 at 6 months after ESG. These patients will not be candidate for revision regardless of the randomization group. * Patients with a contraindication to MRI may be included in the study and will follow the "No Imaging" study design.
๐Ÿ’Š

What it tests

  • Endoscopic placement of additional sutures
๐Ÿ“

Where

1 site
Service de chirurgie digestive et endocrinienne, NHC
Strasbourg, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy